[Hematopoietic stem cell transplantation in pediatric onco-hematology]
- PMID: 11388047
[Hematopoietic stem cell transplantation in pediatric onco-hematology]
Abstract
Hematopoietic stem cell transplantation (HSCT) represents today an important therapeutic choice for several disorders of childhood: hematologic, metabolic and neoplastic pathologies can be treated with this strategy. The aim of this paper is to resume the latest history of HSCT, paying attention to the main changes and controversies, and its efficacy as far as concerns the major indications in pediatric oncohematology.
Similar articles
-
Allogeneic bone marrow transplantation in hematologic disorders of childhood: new trends and controversies.Haematologica. 2000 Nov;85(11 Suppl):2-8. Haematologica. 2000. PMID: 11268319 Review.
-
Expanding indications for stem cell transplantation.Semin Oncol Nurs. 2009 May;25(2):105-14. doi: 10.1016/j.soncn.2009.03.002. Semin Oncol Nurs. 2009. PMID: 19411013 Review.
-
[Summary of the 16th National Conference of Pediatric Hematology].Zhonghua Er Ke Za Zhi. 2013 Jan;51(1):76-7. Zhonghua Er Ke Za Zhi. 2013. PMID: 23527938 Chinese. No abstract available.
-
[Indications for hematopoietic stem cell transplantation in pediatric oncology and hematology in the year 2003].Przegl Lek. 2003;60 Suppl 5:35-40. Przegl Lek. 2003. PMID: 14575006 Review. Polish.
-
Stem cell transplantation in Europe: trends and prospects.Eur J Cancer. 2007 Nov;43(16):2359-65. doi: 10.1016/j.ejca.2007.08.020. Epub 2007 Oct 4. Eur J Cancer. 2007. PMID: 17919900 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical